ResultsIQ › Latest results › Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Limited call transcript summary
NSE: FREDUN · BSE: 539730
Call transcript of 6 Jun 2026, summarised by AI from the filing.
Fredun Pharmaceuticals will host its Q4 FY26 earnings conference call on Wednesday, 10th June, 2026 at 11:00 a.m.
Key takeaways
- Call date Fredun Pharmaceuticals will host its Q4 FY26 earnings conference call on Wednesday, 10th June, 2026 at 11:00 a.m.
- Dial-in Dial-in numbers are +91 22 6280 1239 and +91 22 7115 8140, with registration through a Chorus Call link.
- Speakers Mr. Fredun Medhora, Managing Director, is listed as the speaker from management.
- Organiser Kirin Advisors invited investors to the Q4 FY26 earnings call.
- Filing The intimation was filed with BSE under Regulation 30 of SEBI LODR Regulations, 2015.
Fredun Pharmaceuticals Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (13 Aug 2026)
- Q4 FY26: Earnings call (10 Jun 2026)
- Q3 FY26: Earnings call (12 Feb 2026)
- Q2 FY26: Earnings call (11 Nov 2025)
- Q1 FY26: Earnings call (1 Aug 2025)
- Other events: Call transcript (6 Jun 2026), Strategy deck (10 Jun 2025), Strategy deck (10 Jun 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.